Robert Udelsman, MD

Robert Udelsman, M.D., MBA, FACS, FACE, is chief of endocrine surgery and director of the Endocrine Neoplasia Institute at Baptist Health Herbert Wertheim Cancer Institute. He is renowned for his innovative and highly successful surgical approach for performing parathyroid and thyroid operations. He has dedicated much of his career to the development of minimally invasive endocrine procedures, performing more than 7,000 thyroid and 6,000 parathyroid procedures. He was one of the first in the world to pioneer minimally invasive parathyroidectomy and the first in the U.S. to perform thyroid and parathyroidectomies via the mouth, avoiding visible scarring on the neck. He also was an early adopter of laparoscopic adrenalectomy. Dr. Udelsman served as the William H. Carmalt professor of surgery and oncology and chair of surgery at Yale University School of Medicine. Prior to joining Herbert Wertheim Cancer Institute, he was surgeon-in-chief at Yale-New Haven Hospital and leader of the Endocrine Cancer Disease Center at Smilow Cancer Hospital, both in New Haven, Conn. Dr. Udelsman is board certified in surgery. He completed his medical training at George Washington University School of Medicine and Health Sciences in Washington, D.C., and his surgical residency and chief residency at the Johns Hopkins Hospital in Baltimore, Md. He also completed three fellowships: surgical oncology at the National Cancer Institute; endocrinology at the National Institute of Child Health and Human Development; and gastrointestinal surgery at the Johns Hopkins Hospital. Dr. Udelsman’s clinical research results have appeared in more than 400 publications. He has been honored with numerous awards and is a member of 30 national and international professional societies and seven scientific journal editorial boards. At the Miami Cancer Institute he has developed a robust endocrine center focused on the management of thyroid, parathyroid and adrenal disease.